Understanding ENPP1 Deficiency

Getting the Diagnosis Right: Understanding ENPP1 Deficiency

A recent survey revealed that many individuals affected by ENPP1 Deficiency—patients and caregivers alike—are still unsure about the correct name for their condition. When presented with three choices:

1. GACI caused by ENPP1 Deficiency
2. ARHR2 caused by ENPP1 Deficiency
3. GACI and subsequently ARHR2 caused by ENPP1 Deficiency

—many respondents selected an option that didn’t match the symptoms they described. For example, some who chose ARHR2 mentioned vascular calcifications, which are more typical of GACI. Others who selected GACI shared experiences with rickets medications and bone pain, which are more often linked to ARHR2.

This confusion is understandable—and it highlights the need for continued education about ENPP1 Deficiency and the complications it causes throughout a person’s life.

What Is ENPP1 Deficiency?

ENPP1 Deficiency is a genetic condition caused by mutations in the ENPP1 gene. It affects how the body regulates calcium and phosphate, leading to a range of health issues that can change over time.

The most well-known complications of ENPP1 Deficiency are:

• GACI (Generalized Arterial Calcification of Infancy): A life-threatening condition in infancy where calcium builds up in the arteries, potentially causing cardiovascular problems.
• ARHR2 (Autosomal Recessive Hypophosphatemic Rickets Type 2): A form of rickets that typically develops in early childhood, but can develop later, leading to bone deformity, bone pain, fractures, and growth issues due to low phosphate levels.
  

Importantly, GACI and ARHR2 are not separate diseases—they are manifestations of ENPP1 Deficiency at different stages of life. Other symptoms, like hearing loss, dental issues, calcific enthesopathies, or cervical spine fusion, may also appear as patients age.

Why the Right Name Matters

For many years, families and clinicians referred to the condition as “GACI,” even when rickets or other symptoms developed later on. That made sense before we understood the full picture. Today, we know that ENPP1 Deficiency is the correct diagnosis, and GACI and ARHR2 are two of the ways it can show up.

Using the correct term matters because:

• It leads to more accurate and coordinated care across specialties.
• It strengthens our community voice in advocacy and research.
• It ensures that all parts of the condition—not just the earliest symptoms—are recognized and treated.
  

Moving Forward as a Community

At Brighter Hope Foundation, we’ve worked to update the language across our website and resources to reflect this clearer understanding. Still, we know there’s more work to do.

We encourage families to:

• Talk to healthcare providers about ENPP1 Deficiency as the overall diagnosis.
• Use the term when connecting with others in the community.
• Help spread awareness so others can better understand their own journey.
  

Together, we can ensure that everyone affected by ENPP1 Deficiency receives the care, support, and recognition they deserve—no matter which symptoms appear first.

If you have questions or want to learn more, please visit our information pages or contact us directly.